AGER and metabolic dysfunction-associated steatotic liver disease: Chandrashekaran et al. also identified systemic circulating HMGB1, acting via RAGE, as a key mediator accelerating intestinal inflammation in NAFLD (Chandrashekaran et al. 2017).